2008 Manual of Motorcycle Sport - Motorcycling Australia

and provide accurate and up-to-date
whereabouts information for this
purpose when identified for inclusion
in a Registered Testing Pool;
d) Take full responsibility, in the context
of anti-doping, for what they ingest
and Use;
e) Inform medical personnel of their
obligations not to Use Prohibited
Substances and Prohibited Methods
and to take responsibility to make
sure that any medical treatment
received does not violate anti-doping
policies and rules applicable to them;
f) Immediately refer information about
possible Anti-Doping Rule Violations
to ASADA;
g) Assist, cooperate and liaise with
ASADA and other Anti-Doping
Organisations in relation to the
conduct of any investigation or
hearing into an alleged Anti-Doping
Rule Violation;
h) Act in a discreet and confidential
manner in discharging their
obligations under this ADP; and
i) Who are not regular Members of MA,
be available for Sample collection
and provide accurate and up-todate
whereabouts information on
a regular basis if required by the
conditions of eligibility established
by any applicable Anti-Doping
Organisation.
11.5.0.3 Athlete Support Personnel must:
a) Know and comply with all antidoping
policies and rules applicable
to them or the Athletes whom they
support. These include, but may not
be limited to this ADP; the FIM Anti-
Doping Policy and the NAD Scheme;
b) Support and assist Anti-Doping
Organisations, including ASADA to
conduct Doping Control;
c) Use their influence on Athletes’
values and behaviour to foster antidoping
attitudes;
d) Immediately refer information about
possible Anti-Doping Rule Violations
to ASADA;
e) Assist, cooperate and liaise with
ASADA and other Anti-Doping
Organisations in relation to the
conduct of any investigation or
hearing into an alleged Anti-Doping
Rule Violation; and
f) Act in a discreet and confidential
manner in discharging their
obligations under this ADP.
11.6 DEFINITION OF DOPING
11.6.0.1 Doping is defined as the occurrence of 1
or more of the Anti-Doping Rule Violations
set out in Article 2 of the Code (see- www.
wada-ama.org).
11.7 PROOF OF DOPING
11.7.0.1 Article 3 of the Code applies (www.wadaama.org).
11.8 ANTI-DOPING PROHIBITED LIST
11.8.0.1 This ADP incorporates the WADA
Prohibited List and otherwise applies
Article 4 of the Code (www.wada-ama.
org).
11.8.0.2 Athletes with a documented medical
condition requiring the Use of a Prohibited
Substance or a Prohibited Method must
first obtain a Therapeutic Use Exemption
(TUE) from the Australian Sports Drug
Medical Advisory Committee established
by the Australian Sports Drug Agency Act
1990 (Cth) and continued by the ASADA
Act or other recognised Therapeutic Use
Exemption Committee in accordance with
the WADA International TUE Standard.
11.8.0.3 TUEs granted by a Therapeutic Use
Exemption Committee must be reported to
other relevant Anti-Doping Organisations
including ASADA.
11.9 ANTI-DOPING TESTING
11.9.0.1 All Athletes subject to Doping Control
agree to submit to In-Competition Testing
and Out-of-Competition Testing (at any
time or place, with or without advance
notice) by an Anti-Doping Organisation.
ASADA may test any athlete, any time,
anywhere.
11.9.0.2 All Testing shall be conducted in conformity
with the WADA International Standard for
Testing in force at the time of Testing.
11.9.0.3 Athletes must comply with their obligations
2008 MANUAL OF MOTORCYCLE SPORT enjoy the ride
11 ANTI - DOPING POLICY
79